GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $177,000 | +43.9% | 2,595 | -38.2% | 0.01% | +50.0% |
| Q4 2021 | $123,000 | -11.5% | 4,202 | -22.9% | 0.00% | -20.0% |
| Q3 2021 | $139,000 | -87.3% | 5,452 | -82.6% | 0.01% | -86.1% |
| Q2 2021 | $1,095,000 | +338.0% | 31,273 | +409.1% | 0.04% | +350.0% |
| Q1 2021 | $250,000 | +1215.8% | 6,143 | +1573.8% | 0.01% | 0.0% |
| Q1 2020 | $19,000 | -36.7% | 367 | -1.6% | 0.01% | +14.3% |
| Q4 2019 | $30,000 | +2900.0% | 373 | +3290.9% | 0.01% | – |
| Q3 2019 | $1,000 | 0.0% | 11 | -45.0% | 0.00% | – |
| Q3 2018 | $1,000 | -98.9% | 20 | -99.0% | 0.00% | -100.0% |
| Q2 2018 | $89,000 | +368.4% | 1,971 | +220.5% | 0.03% | +130.8% |
| Q3 2017 | $19,000 | -54.8% | 615 | -60.4% | 0.01% | -70.5% |
| Q2 2017 | $42,000 | – | 1,553 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |